Cargando…

218 Azole-Induced Pseudo Hyperaldosteronism With Therapeutic Levels of Posaconazole

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Inc. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935038/ http://dx.doi.org/10.1053/j.ajkd.2022.01.223

Ejemplares similares

Pseudo Hyperaldosteronism Secondary to Herbal Medicine Use
por: Khan, Omair, et al.
Publicado: (2022)

In Vitro Activity of the Antifungal Azoles Itraconazole and Posaconazole against Leishmania amazonensis
por: de Macedo-Silva, Sara Teixeira, et al.
Publicado: (2013)

Acquisition of cross-azole tolerance and aneuploidy in Candida albicans strains evolved to posaconazole
por: Kukurudz, Rebekah J, et al.
Publicado: (2022)

High‐dose posaconazole for azole‐resistant aspergillosis and other difficult‐to‐treat mould infections
por: Schauwvlieghe, Alexander F. A. D., et al.
Publicado: (2019)

Successful Treatment of Chronic Mucocutaneous Candidiasis Caused by Azole-Resistant Candida albicans with Posaconazole
por: Firinu, Davide, et al.
Publicado: (2011)

Successful treatment of azole-resistant invasive aspergillosis in a bottlenose dolphin with high-dose posaconazole
por: Bunskoek, Paulien E., et al.
Publicado: (2017)

Itraconazole, Voriconazole, and Posaconazole CLSI MIC Distributions for Wild-Type and Azole-Resistant Aspergillus fumigatus Isolates
por: Buil, Jochem B., et al.
Publicado: (2018)

A Novel, Rapid, and Low-Volume Assay for Therapeutic Drug Monitoring of Posaconazole and Other Long-Chain Azole-Class Antifungal Drugs
por: Wiedman, Gregory R., et al.
Publicado: (2018)

Therapeutic Drug Monitoring of Posaconazole: an Update
por: Dekkers, Bart G. J., et al.
Publicado: (2016)

Neuroblastoma accompanied by hyperaldosteronism
por: Gulleroglu, Kaan, et al.
Publicado: (2014)

Comparative activity of posaconazole and systemic azole agents against clinical isolates of filamentous fungi from a global surveillance programme
por: Carvalhaes, Cecilia G, et al.
Publicado: (2021)

Exposure of Cryptococcus neoformans to Seven Commonly Used Agricultural Azole Fungicides Induces Resistance to Fluconazole as Well as Cross-Resistance to Voriconazole, Posaconazole, Itraconazole and Isavuconazole
por: Drakulovski, Pascal, et al.
Publicado: (2023)

Posaconazole and isavuconazole induced hypomagnesaemia
por: Burston, John, et al.
Publicado: (2018)

974. Real World Experience of Posaconazole Therapeutic Drug Monitoring in Oncology Patients: Clinical Implications of Hypoalbuminemia as a Predictor of Subtherapeutic Posaconazole Levels
por: Pasikhova, Yanina, et al.
Publicado: (2023)

Posaconazole therapeutic drug monitoring in clinical practice and longitudinal analysis of the effect of routine laboratory measurements on posaconazole concentrations
por: Märtson, Anne‐Grete, et al.
Publicado: (2019)

On the effect of hyperaldosteronism-inducing mutations in Na/K pumps
por: Meyer, Dylan J., et al.
Publicado: (2017)

Posaconazole for lobomycosis
por: Pasqualotto, Alessandro C., et al.
Publicado: (2021)

Changes in the Perceived Epidemiology of Primary Hyperaldosteronism
por: Fagugli, Riccardo Maria, et al.
Publicado: (2011)

Mineralocorticoid hypertension and hypokalaemia induced by posaconazole
por: Boughton, Charlotte, et al.
Publicado: (2018)

Posaconazole-Induced Apparent Mineralocorticoid Excess
por: Pandit, Amar, et al.
Publicado: (2020)

2546. Administration of Crushed Posaconazole Delayed Release Tablets Failed to Achieve Therapeutic Levels
por: Kane, Nicholas, et al.
Publicado: (2023)

Primary hyperaldosteronism: challenges in subtype classification
por: Layden, Brian T, et al.
Publicado: (2012)

An Association of Chronic Hyperaldosteronism with Medullary Nephrocalcinosis
por: Mittal, Kartik, et al.
Publicado: (2015)

Central serous chorioretinopathy in primary hyperaldosteronism
por: van Dijk, Elon H. C., et al.
Publicado: (2016)

Multiple corticosteroid abnormalities in cats with hyperaldosteronism
por: Langlois, Daniel K., et al.
Publicado: (2021)

FRI416 Primary Hyperaldosteronism in Pregnancy
por: Seav, Susan M, et al.
Publicado: (2023)

Pharmacokinetics and Pharmacodynamics of Posaconazole
por: Chen, Lu, et al.
Publicado: (2020)

732. Posaconazole Serum Drug Levels Associated with Pseudohyperaldosteronism
por: Nguyen, Minh-Vu Hoang, et al.
Publicado: (2019)

Dose Optimisation of Posaconazole and Therapeutic Drug Monitoring in Pediatric Patients
por: Jia, Mengmeng, et al.
Publicado: (2022)

Voriconazole and posaconazole therapeutic drug monitoring: a retrospective study
por: Yi, Whitley M., et al.
Publicado: (2017)

Posaconazole-Induced Hypertension and Hypokalemia: Mechanistic Evaluation
por: Thompson, George R, et al.
Publicado: (2017)

Posaconazole‐induced hypertension in children with cystic fibrosis
por: Marpole, Rachael, et al.
Publicado: (2021)

LBODP014 Hyperaldosteronism Caused By Adrenal Cyst
por: Vargas, Laura Valentina Estupiñan, et al.
Publicado: (2022)

Topical Diagnosis and Determination of the Primary Hyperaldosteronism Variant
por: Shidlovskyi, Viktor O., et al.
Publicado: (2019)

Primary Hyperaldosteronism in Pregnancy: A Case Report
por: Li, Jefferson, et al.
Publicado: (2021)

Hyperaldosteronism in a Patient With Gastrointestinal Potassium Wasting
por: Amankwah, Samuel, et al.
Publicado: (2021)

Adrenal Venous Sampling for Subtype Diagnosis of Primary Hyperaldosteronism
por: Naruse, Mitsuhide, et al.
Publicado: (2021)

Abstract 118: Primary hyperaldosteronism presenting as subarachnoid hemorrhage
por: Panikar, Krish, et al.
Publicado: (2022)

Outcome of Patients Undergoing Laparoscopic Adrenalectomy for Primary Hyperaldosteronism
por: Goh, Brian K. P., et al.
Publicado: (2004)

Symptomatic Hypocalcemia in Primary Hyperaldosteronism: A Case Report
por: Pai, Sachin G, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_t6gh156hhenbqb6g83mn91s3a1